CYCLACEL PHARMACEUTICALS INC (CYCC)
US23254L8019 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to CYCC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 221.36% above the current price.
CYCC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CYCC.
In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
CYCC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-03 | Roth MKM | Maintains | Buy -> Buy |
| 2023-12-19 | Roth MKM | Maintains | Buy -> Buy |
| 2023-12-19 | Brookline Capital | Downgrade | Buy -> Hold |
| 2023-05-25 | Oppenheimer | Maintains | Outperform |
| 2023-03-07 | Oppenheimer | Maintains | Outperform |
| 2021-04-30 | Oppenheimer | Initiate | Outperform |